Vortioxetine promotes early changes in dendritic morphology compared to fluoxetine in rat hippocampus

European Neuropsychopharmacology

Volumn 26, Issue 2, 2016, Pages 234-245

  Chen, Fenghua ^a,b   Du Jardin, Kristian Gaarn ^b   Waller, Jessica A ^c   Sanchez, Connie ^b,c   Nyengaard, Jens R ^a   Wegener, Gregers ^b,d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c LUNDBECK RESEARCH USA   (United States)

^d NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Antidepressant; Dendrite; Length; Number; Spine

Indexed keywords

FLUOXETINE; VORTIOXETINE; ANTIDEPRESSANT AGENT; PIPERAZINE DERIVATIVE; SULFIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; DENDRITIC CELL; DENDRITIC SPINE; DRUG EFFECT; HIPPOCAMPAL CA1 REGION; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; ANALYSIS OF VARIANCE; ANIMAL; CYTOLOGY; DRUG EFFECTS; HIPPOCAMPUS; SILVER STAINING; SPRAGUE DAWLEY RAT; TIME FACTOR; ULTRASTRUCTURE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; DENDRITES; DENDRITIC SPINES; FLUOXETINE; HIPPOCAMPUS; MALE; PIPERAZINES; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; SILVER STAINING; SULFIDES; TIME FACTORS;

EID: 84958125495     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.12.018     Document Type: Article

References (76)

1. Araya R., Vogels T.P., Yuste R. Activity-dependent dendritic spine neck changes are correlated with synaptic strength. Proc. Natl. Acad. Sci. USA 2014, 111(28):E2895-E2904.
2. Arellano J.I., Benavides-Piccione R., Defelipe J., Yuste R. Ultrastructure of dendritic spines: correlation between synaptic and spine morphologies. Front. Neurosci. 2007, 1(1):131-143.
3. Ariav G., Polsky A., Schiller J. Submillisecond precision of the input-output transformation function mediated by fast sodium dendritic spikes in basal dendrites of CA1 pyramidal neurons. J. Neurosci. 2003, 23(21):7750-7758.
4. Artigas F. Serotonin receptors involved in antidepressant effects. Pharmacol. Ther. 2013, 137(1):119-131.
5. Ascoli G.A., Alonso-Nanclares L., Anderson S.A., Barrionuevo G., Benavides-Piccione R., Burkhalter A., et al. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat. Rev. Neurosci. 2008, 9(7):557-568.
6. Barco A., Marie H. Genetic approaches to investigate the role of CREB in neuronal plasticity and memory. Mol. Neurobiol. 2011, 44(3):330-349.
7. Campbell S., Macqueen G. The role of the hippocampus in the pathophysiology of major depression. J. Psychiatry Neurosci. 2004, 29(6):417-426.
8. Carlisle H.J., Kennedy M.B. Spine architecture and synaptic plasticity. Trends Neurosci. 2005, 28(4):182-187.
9. Chang P.K., Prenosil G.A., Verbich D., Gill R., McKinney R.A. Prolonged ampakine exposure prunes dendritic spines and increases presynaptic release probability for enhanced long-term potentiation in the hippocampus. Eur. J. Neurosci. 2014, 40(5):2766-2776.
10. Chen F., Madsen T.M., Wegener G., Nyengaard J.R. Changes in rat hippocampal CA1 synapses following imipramine treatment. Hippocampus 2008, 18(7):631-639.
11. Chen F., Madsen T.M., Wegener G., Nyengaard J.R. Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus. Eur. Neuropsychopharmacol. 2009, 19(5):329-338.
12. Chen F., Madsen T.M., Wegener G., Nyengaard J.R. Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression. Hippocampus 2010, 20(12):1376-1384.
13. Cope D.W., Maccaferri G., Marton L.F., Roberts J.D., Cobden P.M., Somogyi P. Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience 2002, 109(1):63-80.
14. Coppell A.L., Pei Q., Zetterstrom T.S. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 2003, 44(7):903-910.
15. Croarkin P.E., Levinson A.J., Daskalakis Z.J. Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci. Biobehav. Rev. 2011, 35(3):818-825.
16. Dale, E., Lu, D., Liu, H., Yang, C.R., Sanchez, C., 2015. Vortioxetine disinhibits pyramidal cells by blocking serotonin excitation of GABAergic interneurons in the hippocampus. In: Proceedings of the SOBP Poster Session, 341.
17. Dale E., Zhang H., Leiser S.C., Xiao Y., Lu D., Yang C.R., Plath N., Sanchez C. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. J. Psychopharmacol. 2014, 28(10):891-902.
18. DeFelipe J., Lopez-Cruz P.L., Benavides-Piccione R., Bielza C., Larranaga P., Anderson S., et al. New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat. Rev. Neurosci. 2013, 14(3):202-216.
19. Di C.G., Wu C., Chattopadhyaya B., Ango F., Knott G., Welker E., Svoboda K., Huang Z.J. Subcellular domain-restricted GABAergic innervation in primary visual cortex in the absence of sensory and thalamic inputs. Nat. Neurosci. 2004, 7(11):1184-1186.
20. Dincheva I., Glatt C.E., Lee F.S. Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics. Neuroscientist 2012, 18(5):439-451.
21. du Jardin K.G., Liebenberg N., Sanchez C., Wegener G., Elfving B. Single dose vortioxetine or ketamine but not fluoxetine increases expression of neuroplasticity related genes in the rat prefrontal cortex. Eur. Neuropsychopharm. 2013, 23:S392. Ref Type: Generic.
22. Duman R.S. Neural plasticity: consequences of stress and actions of antidepressant treatment. Dialogues Clin. Neurosci. 2004, 6(2):157-169.
23. Ferezou I., Cauli B., Hill E.L., Rossier J., Hamel E., Lambolez B. 5-HT3 receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/cholecystokinin interneurons. J. Neurosci. 2002, 22(17):7389-7397.
24. Gabbay V., Mao X., Klein R.G., Ely B.A., Babb J.S., Panzer A.M., Alonso C.M., Shungu D.C. Anterior cingulate cortex gamma-aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch. Gen. Psychiatry 2012, 69(2):139-149.
25. Gong N., Li Y., Cai G.Q., Niu R.F., Fang Q., Wu K., Chen Z., Lin L.N., Xu L., Fei J., Xu T.L. GABA transporter-activity modulates hippocampal theta oscillation and theta burst stimulation-induced long-term potentiation. J. Neurosci. 2009, 29(50):15836-15845.
26. Guilloux J.P., Mendez-David I., Pehrson A., Guiard B.P., Reperant C., Orvoen S., Gardier A.M., Hen R., Ebert B., Miller S., Sanchez C., David D.J. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology 2013, 73C:147-159.
27. Hajszan T., Dow A., Warner-Schmidt J.L., Szigeti-Buck K., Sallam N.L., Parducz A., Leranth C., Duman R.S. Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol. Psychiatry 2009, 65(5):392-400.
28. Hajszan T., Szigeti-Buck K., Sallam N.L., Bober J., Parducz A., Maclusky N.J., Leranth C., Duman R.S. Effects of estradiol on learned helplessness and associated remodeling of hippocampal spine synapses in female rats. Biol. Psychiatry 2010, 67(2):168-174.
29. Han, H.A., Cortez, M.A., Snead, O.C. 2012. GABAB Receptor and Absence Epilepsy.
30. Kang H.J., Voleti B., Hajszan T., Rajkowska G., Stockmeier C.A., Licznerski P., Lepack A., Majik M.S., Jeong L.S., Banasr M., Son H., Duman R.S. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat. Med. 2012, 18(9):1413-1417.
31. Kasai H., Matsuzaki M., Noguchi J., Yasumatsu N., Nakahara H. Structure-stability-function relationships of dendritic spines. Trends Neurosci. 2003, 26(7):360-368.
32. Khawaja X., Xu J., Liang J.J., Barrett J.E. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies. J. Neurosci. Res. 2004, 75(4):451-460.
33. Klausberger T. GABAergic interneurons targeting dendrites of pyramidal cells in the CA1 area of the hippocampus. Eur. J. Neurosci. 2009, 30(6):947-957.
34. Kramar E.A., Lynch G. Developmental and regional differences in the consolidation of long-term potentiation. Neuroscience 2003, 118(2):387-398.
35. Kucukibrahimoglu E., Saygin M.Z., Caliskan M., Kaplan O.K., Unsal C., Goren M.Z. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. Eur. J. Clin. Pharmacol. 2009, 65(6):571-577.
36. Leung L.S., Shen B., Kaibara T. Long-term potentiation induced by patterned stimulation of the commissural pathway to hippocampal CA1 region in freely moving rats. Neuroscience 1992, 48(1):63-74.
37. Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., Li X.Y., Aghajanian G., Duman R.S. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329(5994):959-964.
38. Li N., Liu R.J., Dwyer J.M., Banasr M., Lee B., Son H., Li X.Y., Aghajanian G., Duman R.S. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol. Psychiatry 2011, 69(8):754-761.
39. Licznerski P., Duman R.S. Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression. Neuroscience 2013, 251:33-50.
40. Lucas G., Rymar V.V., Du J., Mnie-Filali O., Bisgaard C., Manta S., Lambas-Senas L., Wiborg O., Haddjeri N., Pineyro G., Sadikot A.F., Debonnel G. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 2007, 55(5):712-725.
41. Luscher B., Shen Q., Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol. Psychiatry 2011, 16(4):383-406.
42. Maccaferri G., McBain C.J. The hyperpolarization-activated current (Ih) and its contribution to pacemaker activity in rat CA1 hippocampal stratum oriens-alveus interneurones. J. Physiol. 1996, 497:119-130.
43. Magarinos A.M., Deslandes A., McEwen B.S. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur. J. Pharmacol. 1999, 371(2-3):113-122.
44. Malberg J.E. Implications of adult hippocampal neurogenesis in antidepressant action. J. Psychiatry Neurosci. 2004, 29(3):196-205.
45. Marcussen A.B., Flagstad P., Kristjansen P.E., Johansen F.F., Englund U. Increase in neurogenesis and behavioural benefit after chronic fluoxetine treatment in Wistar rats. Acta Neurol. Scand. 2008, 117(2):94-100.
46. Mathers, C.D., Salomon, J.A., Ezzati, M., Begg, S., Hoorn, S.V., Lopez, A.D., 2006. Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates.
47. McAllister A.K. Cellular and molecular mechanisms of dendrite growth. Cereb. Cortex 2000, 10(10):963-973.
48. McAllister A.K., Katz L.C., Lo D.C. Neurotrophin regulation of cortical dendritic growth requires activity. Neuron 1996, 17(6):1057-1064.
49. McAvoy K., Russo C., Kim S., Rankin G., Sahay A. Fluoxetine induces input-specific hippocampal dendritic spine remodeling along the septotemporal axis in adulthood and middle age. Hippocampus 2015.
50. McMahon L.L., Kauer J.A. Hippocampal interneurons express a novel form of synaptic plasticity. Neuron 1997, 18(2):295-305.
51. Moser M.B., Trommald M., Andersen P. An increase in dendritic spine density on hippocampal CA1 pyramidal cells following spatial learning in adult rats suggests the formation of new synapses. Proc. Natl. Acad. Sci. USA 1994, 91(26):12673-12675.
52. Navakkode S., Sajikumar S., Korte M., Soong T.W. Dopamine induces LTP differentially in apical and basal dendrites through BDNF and voltage-dependent calcium channels. Learn. Mem. 2012, 19(7):294-299.
53. Nimchinsky E.A., Sabatini B.L., Svoboda K. Structure and function of dendritic spines. Annu. Rev. Physiol. 2002, 64:313-353.
54. Okamoto H., Voleti B., Banasr M., Sarhan M., Duric V., Girgenti M.J., Dileone R.J., Newton S.S., Duman R.S. Wnt2 expression and signaling is increased by different classes of antidepressant treatments. Biol. Psychiatry 2010, 68(6):521-527.
55. Pawelzik H., Hughes D.I., Thomson A.M. Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurones in CA1 of the adult rat hippocampus. J. Comp. Neurol. 2002, 443(4):346-367.
56. Pehrson A.L., Sanchez C. Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction. CNS Spectr. 2014, 19(2):121-133.
57. Pehrson A.L., Sanchez C. Altered gamma-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Drug Des. Dev.Ther. 2015, 9:603-624.
58. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33(1):88-109.
59. Puig M.V., Santana N., Celada P., Mengod G., Artigas F. In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cereb. Cortex 2004, 14(12):1365-1375.
60. Ramachandran B., Ahmed S., Dean C. Long-term depression is differentially expressed in distinct lamina of hippocampal CA1 dendrites. Front. Cell. Neurosci. 2015, 9:23.
61. Ren Z., Sahir N., Murakami S., Luellen B.A., Earnheart J.C., Lal R., Kim J.Y., Song H., Luscher B. Defects in dendrite and spine maturation and synaptogenesis associated with an anxious-depressive-like phenotype of GABAA receptor-deficient mice. Neuropharmacology 2015, 88:171-179.
62. Sajikumar S., Navakkode S., Frey J.U. Identification of compartment- and process-specific molecules required for "synaptic tagging" during long-term potentiation and long-term depression in hippocampal CA1. J. Neurosci. 2007, 27(19):5068-5080.
63. Sanacora G., Mason G.F., Rothman D.L., Hyder F., Ciarcia J.J., Ostroff R.B., Berman R.M., Krystal J.H. Increased cortical GABA concentrations in depressed patients receiving ECT. Am. J. Psychiatry 2003, 160(3):577-579.
64. Sanchez C., Asin K.E., Artigas F. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol. Ther. 2015, 145:43-57.
65. Scorza M.C., Llado-Pelfort L., Oller S., Cortes R., Puigdemont D., Portella M.J., Perez-Egea R., Alvarez E., Celada P., Perez V., Artigas F. Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. Br. J. Pharmacol. 2012, 167(5):1021-1034.
66. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss. Am. J. Psychiatry 2003, 160(8):1516-1518.
67. SHOLL D.A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J. Anat. 1953, 87(4):387-406.
68. Spruston N. Pyramidal neurons: dendritic structure and synaptic integration. Nat. Rev. Neurosci. 2008, 9(3):206-221.
69. Stone T.W. Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats. Eur. J. Neurosci. 2007, 25(9):2656-2665.
70. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., Storm D., Duman R.S. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J. Neurosci. 2000, 20(11):4030-4036.
71. Tiraboschi E., Tardito D., Kasahara J., Moraschi S., Pruneri P., Gennarelli M., Racagni G., Popoli M. Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology 2004, 29(10):1831-1840.
72. Turner T.J., Mokler D.J., Luebke J.I. Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies. Neuroscience 2004, 129(3):703-718.
73. Wainwright S.R., Galea L.A. The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus. Neural Plast. 2013, 2013:805497.
74. Waller, J.A., Sanchez, C., 2015. Vortioxetine promotes maturation of dendritic spines - An In vitro study in hippocampus cultures. In: Proceedings of the SOBP Poster Session, 158.
75. Yan W., Wilson C.C., Haring J.H. 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells. Brain Res. Dev. Brain Res. 1997, 98(2):185-190.
76. Yuste R., Bonhoeffer T. Genesis of dendritic spines: insights from ultrastructural and imaging studies. Nat. Rev. Neurosci. 2004, 5(1):24-34.